All data are based on the daily closing price as of December 6, 2024
h

Huons

243070.KQ
16.42 USD
-0.42
-2.49%

Overview

Last close
16.42 usd
Market cap
193.87M usd
52 week high
35.51 usd
52 week low
16.42 usd
Target price
39.1 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
0.475
Price/Book Value
0.8245
Enterprise Value
263.54M usd
EV/Revenue
0.6353
EV/EBITDA
5.297

Key financials

Revenue TTM
402.87M usd
Gross Profit TTM
188.69M usd
EBITDA TTM
52.63M usd
Earnings per Share
N/A usd
Dividend
0.44 usd
Total assets
566.22B usd
Net debt
N/A usd

About

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory system, adrenocortical hormone, enzyme, mineral, solvent, calcium, hemostatic, antidote, antibiotic, metabolic, hyaluronic acid, well-being, anticoagulant, and other tissue cell system products. It also provides eye drop and bio products, as well as medical devices. The company was formerly known as Kwang Myung Pharm and changed its name to Huons Co., Ltd. in June 2003. Huons Co., Ltd. was founded in 1965 and is headquartered in Seongnam-si, South Korea.
  • Symbol
    243070.KQ
  • Exchange
    KQ
  • Isin
    KR7243070000
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Seongnam-si
  • Web site
    https://www.huons.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top